These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7989278

  • 1. A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.
    Steingard S, Allen M, Schooler NR.
    J Clin Psychiatry; 1994 Nov; 55(11):470-2. PubMed ID: 7989278
    [Abstract] [Full Text] [Related]

  • 2. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [Abstract] [Full Text] [Related]

  • 3. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
    Litman RE, Hong WW, Weissman EM, Su TP, Potter WZ, Pickar D.
    J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [Abstract] [Full Text] [Related]

  • 5. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R, Longdon M, Seeman MV.
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [Abstract] [Full Text] [Related]

  • 6. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M, Shah S, Ramkisson R, Murphy S, Zaman R.
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [Abstract] [Full Text] [Related]

  • 7. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS, Gibel A, Ratner Y, Tsinovoy G, Strous RD.
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [Abstract] [Full Text] [Related]

  • 8. Treatment of neuroleptic-resistant schizophrenic relapse.
    Kinon BJ, Kane JM, Johns C, Perovich R, Ismi M, Koreen A, Weiden P.
    Psychopharmacol Bull; 1993 Oct; 29(2):309-14. PubMed ID: 7904762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T, Liraud F, Verdoux H.
    Encephale; 2003 Oct; 29(5):430-7. PubMed ID: 14615692
    [Abstract] [Full Text] [Related]

  • 16. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R.
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [Abstract] [Full Text] [Related]

  • 17. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG, Fleischhacker WW.
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [Abstract] [Full Text] [Related]

  • 18. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H.
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [Abstract] [Full Text] [Related]

  • 19. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM, Andriukaitis S.
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [Abstract] [Full Text] [Related]

  • 20. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B, Palmstierna T.
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.